Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06850168
NA

Clinical Investigation of a Novel Spectacle Lens on Slowing Down Juvenile Myopia Progression

Sponsor: Essilor International

View on ClinicalTrials.gov

Summary

The goal of this exploratory clinical trial is to evaluate the efficacy and safety of a test spectacle lens (standard single vision lens (SVL) during first year, and standard myopia control lens (MCL) in second year), designed with passive red-light emission, for the control of myopia progression in myopic children age 6 to 11 years old, both male and female, with no systemic or ocular anomalies. The main question it aims to answer is: Does the test spectacle lens designed with passive red-light emission provide significant myopia control effect to children? Researchers will compare the standard SVL designed with passive red-light emission to SVL (first year) and MCL designed with passive red-light emission to MCL (second year) to see if the test spectacle lens work to slow down myopia progression. Participants will: * Wear the study spectacles * Visit Essilor R\&D Centre for follow-up sessions

Key Details

Gender

All

Age Range

6 Years - 11 Years

Study Type

INTERVENTIONAL

Enrollment

35

Start Date

2025-06-26

Completion Date

2027-12

Last Updated

2025-08-07

Healthy Volunteers

No

Conditions

Interventions

DEVICE

SVL

Dispensed to one eye in Year 1

DEVICE

SVL with passive red-light emission

Dispensed to the contralateral eye in Year 1.

DEVICE

MCL

Dispensed to one eye in Year 2 (if used SVL with passive red-light emission in Year 1).

DEVICE

MCL with passive red-light emission

Dispensed to the contralateral eye in Year 2 (if used SVL in Year 1).

Locations (1)

Essilor R&D Centre Singapore

Singapore, Singapore